This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
The product will be manufactured at Lupin's Pithampur facility in India
Announces changes to commercial organization to prepare for multiple product launches in 2024 and 2025
Anticipates approx. US$8 billion in revenues for Comirnaty and Paxlovid
Announces changes in the commercial organization to incorporate Seagen and improve focus, speed and execution
First-ever brain chemistry database will allow clinicians to quickly infer brain biomarker data to support the diagnostic process in conditions such as Alzheimer's Disease
We are redesigning Bayer to focus only on what’s essential for our mission, ‘Health for all, hunger for none’”
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
Lupin has been exclusively marketing these brands in the Indian market since July 2021
Subscribe To Our Newsletter & Stay Updated
